177 related articles for article (PubMed ID: 38067268)
1. Involved-Site Radiation Therapy Enables Effective Disease Control in Parenchymal Low-Grade Primary Cerebral Lymphoma.
Pepper NB; Oertel M; Reinartz G; Elsayad K; Hering DA; Yalcin F; Wildgruber M; Stummer W; Lenz G; Klapper W; Eich HT
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067268
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
3. Local Control of Primary Dural Central Nervous System Lymphoma Achieved With Radiotherapy.
Vallejo A; González ID; Guerrero Lizcano E; Forero O; Enciso L
Cureus; 2021 Jun; 13(6):e15735. PubMed ID: 34285846
[TBL] [Abstract][Full Text] [Related]
4. Recurrent primary central nervous system lymphoma complicated by lymphomatous meningitis.
Chamberlain MC; Kormanik P; Glantz M
Oncol Rep; 1998; 5(2):521-5. PubMed ID: 9468593
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
[TBL] [Abstract][Full Text] [Related]
6. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO.
Krogh-Jensen M; d'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Ann Oncol; 1994 Apr; 5(4):349-54. PubMed ID: 8075032
[TBL] [Abstract][Full Text] [Related]
7. Evolution of the treatment of primary central nervous system lymphoma in a Regional Cancer Center of South India: Impact of high-dose methotrexate on treatment outcome.
Rudresha AH; Chaudhuri T; Lakshmaiah KC; Babu G; Lokesh KN; Rajeev LK
J Cancer Res Ther; 2020; 16(1):13-17. PubMed ID: 32362603
[TBL] [Abstract][Full Text] [Related]
8. Low-grade primary central nervous system lymphoma in immunocompetent patients.
Jahnke K; Thiel E; Schilling A; Herrlinger U; Weller M; Coupland SE; Krümpelmann U; Stein H; Korfel A
Br J Haematol; 2005 Mar; 128(5):616-24. PubMed ID: 15725082
[TBL] [Abstract][Full Text] [Related]
9. A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome.
Adhikari N; Biswas A; Gogia A; Sahoo RK; Garg A; Nehra A; Sharma MC; Bhasker S; Singh M; Sreenivas V; Chawla R; Joshi G; Kumar L; Chander S
J Neurooncol; 2018 Aug; 139(1):153-166. PubMed ID: 29633112
[TBL] [Abstract][Full Text] [Related]
10. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
11. Toxicity and efficacy of CAR T-cell therapy in primary and secondary CNS lymphoma: a meta-analysis of 128 patients.
Cook MR; Dorris CS; Makambi KH; Luo Y; Munshi PN; Donato M; Rowley S; Saad A; Goy A; Dunleavy K; Ali A
Blood Adv; 2023 Jan; 7(1):32-39. PubMed ID: 36260735
[TBL] [Abstract][Full Text] [Related]
12. Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes.
Lim T; Kim SJ; Kim K; Lee JI; Lim DH; Lee DJ; Baek KK; Lee HY; Han B; Uhm JE; Ko YH; Kim WS
Ann Hematol; 2011 Dec; 90(12):1391-8. PubMed ID: 21479535
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL).
Nelson DF
J Neurooncol; 1999 Jul; 43(3):241-7. PubMed ID: 10563430
[TBL] [Abstract][Full Text] [Related]
14. Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma.
Zhao D; Qian L; Shen J; Liu X; Mei K; Cen J; Wang Y; Li C; Ma Y
J Cell Mol Med; 2014 Jun; 18(6):1081-6. PubMed ID: 24628986
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy is an efficient treatment in primary CNS MALT lymphoma.
Desjardins C; Larrieu-Ciron D; Choquet S; Mokhtari K; Charlotte F; Nichelli L; Mathon B; Ahle G; Le Garff-Tavernier M; Morales-Martinez A; Dehais C; Hoang-Xuan K; Houillier C
J Neurooncol; 2022 Aug; 159(1):151-161. PubMed ID: 35725885
[TBL] [Abstract][Full Text] [Related]
16. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.
van der Sanden GA; Schouten LJ; van Dijck JA; van Andel JP; van der Maazen RW; Coebergh JW;
Cancer; 2002 Mar; 94(5):1548-56. PubMed ID: 11920513
[TBL] [Abstract][Full Text] [Related]
17. Analysis of primary central nervous system large B-cell lymphoma in the era of high-grade B-cell lymphoma: Detection of two cases with MYC and BCL6 rearrangements in a cohort of 12 cases.
Pina-Oviedo S; Bellamy WT; Gokden M
Ann Diagn Pathol; 2020 Oct; 48():151610. PubMed ID: 32889391
[TBL] [Abstract][Full Text] [Related]
18. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Boron Neutron Capture Therapy in Primary Central Nervous System Lymphoma: In Vitro and In Vivo Evaluation.
Yoshimura K; Kawabata S; Kashiwagi H; Fukuo Y; Takeuchi K; Futamura G; Hiramatsu R; Takata T; Tanaka H; Watanabe T; Suzuki M; Hu N; Miyatake SI; Wanibuchi M
Cells; 2021 Dec; 10(12):. PubMed ID: 34943904
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.
DeAngelis LM; Seiferheld W; Schold SC; Fisher B; Schultz CJ;
J Clin Oncol; 2002 Dec; 20(24):4643-8. PubMed ID: 12488408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
